StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
1033
This month
15
This week
2
This year
108
Today
2
Yesterday
2
Publishing Date
2024 - 01 - 17
5
2023 - 12 - 12
5
2023 - 12 - 11
4
2023 - 12 - 08
5
2023 - 11 - 01
4
2023 - 10 - 30
4
2023 - 10 - 04
4
2023 - 10 - 03
4
2023 - 10 - 02
4
2023 - 09 - 29
4
2023 - 08 - 28
4
2023 - 08 - 25
7
2023 - 08 - 09
5
2023 - 06 - 12
5
2023 - 06 - 08
5
2023 - 04 - 26
5
2023 - 04 - 25
4
2023 - 04 - 13
6
2023 - 04 - 12
12
2023 - 03 - 16
4
2023 - 02 - 27
4
2023 - 02 - 24
4
2023 - 02 - 22
4
2023 - 02 - 20
5
2023 - 02 - 17
7
2023 - 02 - 16
5
2023 - 02 - 13
6
2023 - 02 - 08
4
2023 - 01 - 18
4
2023 - 01 - 16
4
2022 - 09 - 28
4
2022 - 09 - 19
6
2022 - 09 - 02
4
2022 - 08 - 03
4
2022 - 07 - 25
4
2022 - 06 - 27
4
2022 - 06 - 24
4
2022 - 06 - 17
6
2022 - 05 - 27
5
2022 - 05 - 25
4
2022 - 05 - 05
4
2022 - 04 - 26
4
2022 - 03 - 25
6
2022 - 03 - 22
4
2022 - 03 - 17
4
2022 - 03 - 04
4
2022 - 03 - 01
4
2021 - 12 - 22
6
2021 - 12 - 20
4
2021 - 12 - 14
3
2021 - 11 - 12
3
2021 - 11 - 04
3
2021 - 11 - 02
3
2021 - 10 - 28
4
2021 - 10 - 22
3
2021 - 10 - 21
3
2021 - 10 - 20
4
2021 - 10 - 13
3
2021 - 10 - 08
3
2021 - 10 - 01
3
Sector
Commercial services
8
Communications
8
Consumer durables
5
Consumer non-durables
16
Consumer services
2
Distribution services
4
Electronic technology
18
Finance
5
Health care and social assistance
1
Health services
16
Health technology
1033
Industrial services
1
Information
4
Manufacturing
136
Mining, quarrying, and oil and gas extraction
2
N/a
68
Non-energy minerals
1
Process industries
13
Producer manufacturing
16
Professional, scientific, and technical services
18
Retail trade
3
Technology services
16
Tags
Agreement
8
Alzheimer's
10
America
67
Antibody
8
Approval
13
Biosimilar
32
Breast
13
Business
9
Cancer
91
Cell
9
Chmp
10
Diabetes
15
Diagnostics
17
Disease
61
Drug
86
Earnings
18
Europe
15
Expansion
11
Expected
35
Eye
15
Fda
22
Financial
24
Global
228
Growing
43
Growth
236
Health
19
Immunotherapy
11
Infection
9
Key
9
Kisqali
11
Leukemia
10
Liver
11
Market
593
N/a
947
Novartis
133
People
13
Pharma
13
Pharmaceuticals
17
Pipeline
12
Positive
15
Potential
10
Reach
34
Report
194
Research
118
Respiratory
11
Results
38
Risk
10
Sales
10
Sclerosis
13
Set
16
Study
15
T-cell
11
Technology
12
Therapeutics
110
Therapy
64
Treatment
113
Trial
16
Update
10
Vaccine
10
Year
12
Entities
3m company
8
Abbott laboratories
106
Abbvie inc.
218
Abeona therapeutics inc.
7
Adaptimmune therapeutics plc
12
Alcon inc.
14
Alkermes plc
7
Amgen inc.
168
Astellas pharma inc
70
Astrazeneca plc
172
Autolus therapeutics plc
7
Bausch health companies inc.
61
Baxter international inc.
45
Becton, dickinson and company
17
Beigene, ltd.
7
Biogen inc.
47
Biomarin pharmaceutical inc.
6
Biontech se
9
Boston scientific corporation
13
Brainstorm cell therapeutics inc.
8
Bristol-myers squibb company
82
Chinook therapeutics, inc.
7
Csl ltd
9
Danaher corporation
10
Eli lilly and company
121
Endo international plc
20
General electric company
8
Genmab a/s
12
Gilead sciences, inc.
25
Glaxosmithkline plc
265
Grifols sa
10
Incyte corporation
15
Ionis pharmaceuticals, inc.
7
Jazz pharmaceuticals plc
13
Johnson & johnson
189
Koninklijke philips n.v.
17
Mallinckrodt plc
17
Medtronic plc
29
Morphosys ag
13
Novartis ag
1033
Novo nordisk a/s
27
Orange
8
Orchard therapeutics plc
8
Perrigo company
7
Pfizer, inc.
68
Precision biosciences, inc.
8
Reckitt benckiser group plc
10
Regeneron pharmaceuticals, inc.
12
Regenxbio inc.
11
Sanofi
285
Smith & nephew plc
7
Stryker corporation
10
Takeda pharmaceutical company limited
51
Terumo corp
9
Teva pharmaceutical industries limited
9
Teva pharmaceutical industries ltd
206
Thermo fisher scientific inc
48
Ucb s.a.
8
Viatris inc.
115
Xencor, inc.
9
Symbols
AAPL
546
ABB
1433
ABBV
1029
ABLZF
1172
ABT
1795
ACN
602
ARVL
589
BDX
796
BMO
539
BMY
662
BNPQF
654
BNPQY
654
BSX
576
CMI
542
CSCO
532
DELL
578
DHR
785
DOW
556
DUK
528
ERIC
547
F
643
FNCTF
1401
GE
918
GLAXF
660
GOOG
784
GOOGL
785
GSK
887
HON
1791
HUBS
1400
IBM
655
IT
594
JNJ
4590
LLY
1710
LMT
575
LYV
717
MDT
1285
MMM
938
MS
4289
MSFT
808
MT
591
NOC
589
NOK
902
NOKBF
907
NVO
634
NVS
1243
NVSEF
1033
ORCL
1160
PFE
693
PHG
963
SAP
1480
SAPGF
1234
SNOW
796
SNY
1634
SNYNF
1305
STLA
535
SYK
536
TMO
1626
TRU
533
VZ
1218
XYF
677
Exchanges
Amex
6
Nasdaq
1033
Nyse
1033
Crawled Date
2024 - 01 - 17
5
2023 - 12 - 12
5
2023 - 12 - 11
4
2023 - 12 - 08
6
2023 - 11 - 01
4
2023 - 10 - 30
4
2023 - 10 - 04
4
2023 - 10 - 03
4
2023 - 10 - 02
4
2023 - 09 - 29
4
2023 - 08 - 28
4
2023 - 08 - 25
7
2023 - 08 - 09
4
2023 - 06 - 12
5
2023 - 06 - 08
5
2023 - 04 - 28
4
2023 - 04 - 26
5
2023 - 04 - 25
4
2023 - 04 - 13
6
2023 - 04 - 12
12
2023 - 03 - 16
4
2023 - 02 - 27
4
2023 - 02 - 24
4
2023 - 02 - 22
4
2023 - 02 - 20
4
2023 - 02 - 17
7
2023 - 02 - 16
5
2023 - 02 - 14
4
2023 - 02 - 13
4
2023 - 01 - 18
4
2023 - 01 - 16
4
2022 - 12 - 15
4
2022 - 09 - 28
4
2022 - 09 - 19
6
2022 - 09 - 13
4
2022 - 09 - 02
4
2022 - 08 - 03
4
2022 - 07 - 25
4
2022 - 06 - 27
4
2022 - 06 - 24
4
2022 - 06 - 17
6
2022 - 05 - 27
5
2022 - 05 - 25
4
2022 - 05 - 05
4
2022 - 04 - 26
4
2022 - 03 - 25
6
2022 - 03 - 22
4
2022 - 03 - 17
4
2022 - 03 - 14
4
2022 - 03 - 04
4
2021 - 12 - 22
5
2021 - 12 - 20
4
2021 - 11 - 04
3
2021 - 11 - 02
3
2021 - 10 - 28
4
2021 - 10 - 21
3
2021 - 10 - 20
4
2021 - 10 - 13
3
2021 - 10 - 08
3
2021 - 10 - 01
3
Crawled Time
00:00
42
00:20
9
01:00
44
02:00
25
03:00
33
04:00
19
04:20
8
05:00
24
06:00
58
07:00
34
08:00
27
08:20
4
09:00
40
10:00
30
11:00
43
11:01
1
12:00
68
12:20
14
12:30
8
13:00
26
13:15
2
13:20
7
13:30
4
14:00
33
14:15
1
14:20
10
14:30
7
14:49
1
15:00
40
15:15
1
15:20
16
15:30
14
16:00
49
16:20
3
17:00
49
18:00
48
19:00
43
20:00
35
20:20
3
21:00
26
22:00
44
23:00
40
Source
investors.biomarin.com
1
ir.voyagertherapeutics.com
2
www.biospace.com
86
www.globenewswire.com
174
www.perion.com
1
www.precisionbiosciences.com
3
www.prnewswire.com
765
www.voyagertherapeutics.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
NVSEF
exchanges :
Nyse
save search
Novartis delivers double-digit sales growth and core margin expansion in Q1; FY 2024 guidance raised
Published:
2024-04-23
(Crawled : 05:00)
- globenewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
MOR
|
News
|
$17.97
-0.06%
-0.06%
330K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
Email alert
Add to watchlist
MPSYF
|
News
|
$70.28
-71.33%
110
|
Health Technology
|
Email alert
Add to watchlist
sales
expansion
novartis
growth
Over-The-Counter Drug Market size is set to grow by USD 58.54 billion from 2023-2027, Abbott Laboratories, Achelios Therapeutics Inc. and AstraZeneca Plc, and more to emerge as Some of the Key Vendors, Technavio
Published:
2024-04-22
(Crawled : 22:00)
- prnewswire.com
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$70.12
2.29%
2.24%
4.8M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$136.2
-4.19%
1.7K
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
Email alert
Add to watchlist
ABT
|
News
|
$107.07
-0.2%
0.0%
4.9M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$40.59
2.11%
-0.36%
3.8M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
Email alert
Add to watchlist
RBGPF
|
News
|
$51.75
6.46%
3.6K
|
Consumer Non-Durables
|
Email alert
Add to watchlist
RBGLY
|
News
|
$10.35
-2.05%
500K
|
Manufacturing
|
Email alert
Add to watchlist
drug
astrazeneca
set
key
therapeutics
market
Viral Vector and Plasmid DNA Technologies: A Global Market Perspective
Published:
2024-04-17
(Crawled : 10:00)
- prnewswire.com
TMO
|
News
|
$548.38
0.66%
0.29%
1.5M
|
Health Technology
|
-1.6%
|
O:
-0.26%
H:
0.03%
C:
-1.55%
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
2.1%
|
O:
0.87%
H:
0.16%
C:
-0.59%
RGNX
|
$15.68
-0.06%
-0.06%
440K
|
Health Technology
|
-12.36%
|
O:
-1.43%
H:
2.27%
C:
-3.18%
global
dna
market
Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed treatment- naïve people with relapsing multiple sclerosis
Published:
2024-04-17
(Crawled : 06:00)
- globenewswire.com
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
2.1%
|
O:
0.87%
H:
0.16%
C:
-0.59%
kesimpta
sclerosis
novartis
show
benefits
Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published:
2024-04-16
(Crawled : 14:00)
- prnewswire.com
VTRS
|
News
A
|
$11.235
-0.13%
-0.13%
5.1M
|
Health Technology
|
-0.62%
|
O:
-0.53%
H:
0.0%
C:
-1.24%
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
0.61%
|
O:
-1.46%
H:
0.0%
C:
0.0%
PHG
|
News
|
$20.61
3.15%
0.05%
1.6M
|
Health Technology
|
-0.29%
|
O:
-1.21%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.59
2.11%
-0.36%
3.8M
|
Health Technology
|
0.22%
|
O:
-1.19%
H:
0.52%
C:
-0.17%
VRNA
|
$15.75
0.19%
0.19%
460K
|
Health Technology
|
-0.51%
|
O:
1.65%
H:
2.43%
C:
0.87%
reach
treatment
research
market
Ocular Therapeutix™ Strengthens Clinical Team with Appointment of Key Retinal Leaders
Published:
2024-04-16
(Crawled : 11:00)
- globenewswire.com
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
0.61%
|
O:
-1.46%
H:
0.0%
C:
0.0%
REGN
|
News
|
$899.71
0.32%
0.32%
340K
|
Health Technology
|
-1.62%
|
O:
-1.94%
H:
0.43%
C:
-0.34%
OCUL
|
News
|
$5.075
-2.78%
-2.86%
3.7M
|
Health Technology
|
-34.37%
|
O:
-1.03%
H:
3.66%
C:
1.7%
ocular
key
leaders
Biologic Therapeutics Market size is set to grow by USD 286.12 billion from 2023-2027, Introduction of biosimilars boost the market, Technavio
Published:
2024-04-15
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-1.75%
H:
0.85%
C:
0.85%
AZNCF
|
News
|
$136.2
-4.19%
1.7K
|
Health Technology
|
2.05%
|
O:
2.1%
H:
0.0%
C:
-2.52%
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
0.61%
|
O:
-1.46%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.59
2.11%
-0.36%
3.8M
|
Health Technology
|
0.22%
|
O:
-1.19%
H:
0.52%
C:
-0.17%
BAX
|
$40.4
2.36%
0.0%
3.2M
|
Health Technology
|
0.9%
|
O:
-0.1%
H:
0.13%
C:
-1.08%
ABBV
|
News
|
$167.89
0.89%
0.0%
5.6M
|
Health Technology
|
3.85%
|
O:
0.32%
H:
0.96%
C:
0.22%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
-1.27%
|
O:
-2.13%
H:
0.0%
C:
0.0%
BMRN
|
$89.52
1.0%
0.99%
1.2M
|
Health Technology
|
-2.21%
|
O:
-0.72%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.12
2.29%
2.24%
4.8M
|
Health Technology
|
2.04%
|
O:
-0.64%
H:
0.45%
C:
-0.04%
AMGN
|
News
|
$271.98
1.13%
1.12%
2.1M
|
Health Technology
|
2.41%
|
O:
0.41%
H:
0.0%
C:
0.0%
set
therapeutics
market
New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy (IgAN)
Published:
2024-04-15
(Crawled : 18:00)
- globenewswire.com
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
0.61%
|
O:
-1.46%
H:
0.0%
C:
0.0%
fabhalta
nephropathy
for
novartis
show
Novartis tender offer for MorphoSys AG commences
Published:
2024-04-11
(Crawled : 09:00)
- globenewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
1.07%
|
O:
-0.32%
H:
0.48%
C:
-0.17%
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
0.22%
|
O:
0.32%
H:
0.04%
C:
-0.56%
MOR
|
News
|
$17.97
-0.06%
-0.06%
330K
|
Health Technology
|
-0.14%
|
O:
0.69%
H:
0.0%
C:
-0.39%
for
novartis
Central Nervous System (CNS) Stimulant Drugs Market size is set to grow by USD 6.48 billion from 2023-2027, Rise in incidence of CNS disorders boost the market, Technavio
Published:
2024-04-10
(Crawled : 09:00)
- prnewswire.com
ALPMF
|
News
|
$9.75
43.47%
200
|
Health Technology
|
-9.51%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.65%
|
O:
-0.01%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-0.62%
|
O:
-1.67%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.5
-1.11%
1M
|
Manufacturing
|
-8.98%
|
O:
-0.29%
H:
0.0%
C:
-1.97%
VTRS
|
News
A
|
$11.235
-0.13%
-0.13%
5.1M
|
Health Technology
|
-4.01%
|
O:
-0.6%
H:
1.03%
C:
0.52%
TMO
|
News
|
$548.38
0.66%
0.29%
1.5M
|
Health Technology
|
-6.93%
|
O:
-2.01%
H:
0.0%
C:
0.0%
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
-0.94%
|
O:
-1.16%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
-2.64%
|
O:
-0.32%
H:
0.0%
C:
0.0%
JAZZ
|
$108.81
-1.03%
-1.04%
510K
|
Health Technology
|
-5.88%
|
O:
-1.71%
H:
0.57%
C:
0.37%
disorders
system
set
market
Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published:
2024-04-08
(Crawled : 18:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
0.01%
|
O:
2.24%
H:
0.0%
C:
-0.8%
AZNCF
|
News
|
$136.2
-4.19%
1.7K
|
Health Technology
|
4.14%
|
O:
-3.43%
H:
6.21%
C:
6.21%
VTRS
|
News
A
|
$11.235
-0.13%
-0.13%
5.1M
|
Health Technology
|
-4.66%
|
O:
-0.25%
H:
1.1%
C:
-0.17%
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
-1.06%
|
O:
-0.05%
H:
0.43%
C:
-0.27%
BMY
|
$49.14
0.43%
0.0%
7.9M
|
Health Technology
|
-4.25%
|
O:
-0.08%
H:
0.04%
C:
-0.35%
BHC
|
$8.45
-2.76%
0.24%
2.3M
|
Health Technology
|
-18.83%
|
O:
0.38%
H:
0.0%
C:
-7.27%
ABBV
|
News
|
$167.89
0.89%
0.0%
5.6M
|
Health Technology
|
-0.02%
|
O:
0.77%
H:
1.63%
C:
0.35%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
-1.39%
|
O:
0.84%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.12
2.29%
2.24%
4.8M
|
Health Technology
|
3.97%
|
O:
0.18%
H:
0.3%
C:
0.19%
eczema
dermatitis
set
therapeutics
market
New Novartis data show early addition of twice-yearly* Leqvio® (inclisiran) following maximally tolerated statin therapy significantly reduces LDL-C in ASCVD patients in real-world setting
Published:
2024-04-06
(Crawled : 20:20)
- globenewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
Email alert
Add to watchlist
leqvio
novartis
therapy
show
Positron Emission Tomography Market size is set to grow by USD 725.97 mn from 2024-2028,increasing prevalence of chronic conditions worldwide boost the market- Technavio
Published:
2024-04-03
(Crawled : 06:00)
- prnewswire.com
CAJPY
|
$28.23
-0.41%
22K
|
n/a
|
-2.64%
|
O:
-0.3%
H:
0.54%
C:
0.54%
CAJFF
|
$29.0664
-28.15%
760
|
Electronic Technology
|
-2.61%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
0.12%
|
O:
-2.86%
H:
0.17%
C:
0.17%
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
0.38%
|
O:
0.04%
H:
0.46%
C:
-0.08%
PHG
|
News
|
$20.61
3.15%
0.05%
1.6M
|
Health Technology
|
3.46%
|
O:
1.0%
H:
0.0%
C:
0.0%
worldwide
set
market
NewAmsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer
Published:
2024-04-01
(Crawled : 12:00)
- globenewswire.com
NAMS
|
$20.42
2.46%
2.4%
85K
|
n/a
|
-9.71%
|
O:
6.23%
H:
2.77%
C:
-10.21%
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
-1.67%
|
O:
0.47%
H:
0.23%
C:
-0.99%
pharma
business
Carisma Therapeutics Announces Changes to its Board of Directors
Published:
2024-04-01
(Crawled : 11:00)
- prnewswire.com
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
-1.67%
|
O:
0.47%
H:
0.23%
C:
-0.99%
CRIS
|
$14.6
2.03%
1.99%
21K
|
Health Technology
|
37.82%
|
O:
0.7%
H:
16.87%
C:
16.87%
therapeutics
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published:
2024-03-29
(Crawled : 18:00)
- prnewswire.com
BMY
|
$49.14
0.43%
0.0%
7.9M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$66.95
0.29%
0.28%
5.6M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
News
|
$271.98
1.13%
1.12%
2.1M
|
Health Technology
|
Email alert
Add to watchlist
GMAB
|
News
|
$28.97
0.94%
0.93%
450K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
Email alert
Add to watchlist
GNMSF
|
News
|
$284.55
3.83%
240
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$167.89
0.89%
0.0%
5.6M
|
Health Technology
|
Email alert
Add to watchlist
research
global
leukemia
therapeutics
market
LASIK Surgery Market size to record USD 1.24 bn growth from 2024-2028, Increasing medical tourism for LASIK surgery is one of the key market trends, Technavio
Published:
2024-03-28
(Crawled : 22:00)
- prnewswire.com
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
Email alert
Add to watchlist
ABT
|
News
|
$107.07
-0.2%
0.0%
4.9M
|
Health Technology
|
Email alert
Add to watchlist
ALC
|
$80.61
1.33%
0.0%
520K
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
one
key
medical
growth
market
CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
Published:
2024-03-28
(Crawled : 19:00)
- globenewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
Email alert
Add to watchlist
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
Email alert
Add to watchlist
AUTL
|
$4.58
1.33%
1.31%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
medical
Global Antibody Therapeutic Industry Research 2023-2024 & 2033: Exploring the Expanding Role in Managing Cancer, Autoimmune Disorders, and Infectious Diseases
Published:
2024-03-28
(Crawled : 15:30)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-4.25%
|
O:
0.99%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-0.6%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
-1.16%
|
O:
0.52%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-4.47%
|
O:
1.32%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.59
2.11%
-0.36%
3.8M
|
Health Technology
|
-5.58%
|
O:
0.02%
H:
0.51%
C:
-0.3%
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
-6.02%
|
O:
0.28%
H:
1.71%
C:
-0.3%
BMY
|
$49.14
0.43%
0.0%
7.9M
|
Health Technology
|
-7.72%
|
O:
0.26%
H:
2.03%
C:
1.57%
AMGN
|
News
|
$271.98
1.13%
1.12%
2.1M
|
Health Technology
|
-5.03%
|
O:
0.54%
H:
0.0%
C:
0.0%
antibody
research
global
Pharmaceutical Market In Canada size is set to grow by USD 8.73 bn from 2024-2028, Abbott Laboratories, AbbVie Inc. & Amgen Inc., and more to emerge as Some of the Key Vendors, Technavio
Published:
2024-03-27
(Crawled : 22:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-4.25%
|
O:
0.99%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-7.02%
|
O:
-1.17%
H:
0.0%
C:
-0.89%
AZNCF
|
News
|
$136.2
-4.19%
1.7K
|
Health Technology
|
2.99%
|
O:
0.89%
H:
0.78%
C:
0.78%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-0.6%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
-1.16%
|
O:
0.52%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.59
2.11%
-0.36%
3.8M
|
Health Technology
|
-5.58%
|
O:
0.02%
H:
0.51%
C:
-0.3%
BMY
|
$49.14
0.43%
0.0%
7.9M
|
Health Technology
|
-7.72%
|
O:
0.26%
H:
2.03%
C:
1.57%
ABBV
|
News
|
$167.89
0.89%
0.0%
5.6M
|
Health Technology
|
-6.91%
|
O:
0.36%
H:
0.72%
C:
0.61%
ABT
|
News
|
$107.07
-0.2%
0.0%
4.9M
|
Health Technology
|
-4.46%
|
O:
1.04%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
-6.93%
|
O:
-0.96%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.12
2.29%
2.24%
4.8M
|
Health Technology
|
2.74%
|
O:
-0.12%
H:
0.25%
C:
-0.63%
AMGN
|
News
|
$271.98
1.13%
1.12%
2.1M
|
Health Technology
|
-5.03%
|
O:
0.54%
H:
0.0%
C:
0.0%
abbvie
set
canada
key
market
← Previous
1
2
3
4
5
6
7
8
9
…
51
52
Next →
Gainers vs Losers
75%
25%
Top 10 Gainers
MTTR
|
News
M
|
$4.78
174.71%
63.6%
72M
|
AGBA
|
$2.565
105.2%
51.27%
200M
|
Finance
MLEC
|
$2.44
74.29%
42.62%
78M
|
n/a
EDBL
|
News
|
$6.28
67.02%
40.13%
16M
|
ATGL
|
$2.91
48.81%
32.8%
180K
|
ZAPP
|
$0.2175
47.16%
32.05%
16M
|
n/a
ONFO
|
$0.6075
38.38%
27.74%
7.3M
|
n/a
VIVK
|
$1.48
38.32%
27.7%
530K
|
Professional, Scientific, and T...
MNTS
|
$0.5
35.69%
26.3%
4.8M
|
SDIG
A
|
$3.635
35.13%
26.0%
1M
|
Your saved searches
Save your searches and get alerts when important news are released.